• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性头颈癌继发第二癌症的比较治疗与生存结果的首份临床报告:一项基于人群的研究

First Clinical Report on Comparative Treatment and Survival Outcomes in Second Cancers after Primary Head and Neck Cancer: A Population-Based Study.

作者信息

Wang Xin, Mauer Elizabeth A, Christos Paul, Manzerova Julia, Wernicke A Gabriella, Parashar Bhupesh

机构信息

Stich Radiation Oncology, NewYork-Presbyterian/Weill Cornell Medical Center.

Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, New York-Presbyterian/Weill Cornell Medical Center.

出版信息

Cureus. 2017 May 29;9(5):e1284. doi: 10.7759/cureus.1284.

DOI:10.7759/cureus.1284
PMID:28680772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5491341/
Abstract

INTRODUCTION

To compare patients' survival of second primary malignancy (SPM) after head and neck squamous cell carcinoma (HNSCC).

METHODS

The Surveillance, Epidemiology, and End Results (SEER) database was utilized (1973-2011). The Kaplan-Meier method with log-rank test was used to compare the overall survival (OS) and cause-specific survival (CSS) among treatment methods from the time of diagnosis of SPMs. Cox proportional regression models were used to adjust the impact for risk factors on CSS.

RESULTS

A total of 3,038 patients were identified (5-yr OS 22.6% (21.0-24.3%)). For head and neck (HN) SPMs, the patients who received 'conservative surgery with radiation' had the best 5-yr OS (65.2% (48.9-86.9%)); and the 'conservative surgery' group had the best 5-yr CSS (89.9% (85.6-94.5%)). For lung SPMs, the 'radical surgery' group showed the best survival (2-yr OS 60.8% (56.0-66.1%), 2-yr CSS 70.6% (65.8-75.8%), respectively). Esophagus SPMs had poor prognosis, with no difference among the treatment groups. In lung SPMs, younger age (p<0.001) and black race (p<0.05) were most favorable CSS predictors.

CONCLUSIONS

The prognosis of SPMs after HNSCC is worse compared with corresponding primary tumor. Conservative surgery with or without radiation showed the most favorable outcomes in HN SPMs.​.

摘要

引言

比较头颈部鳞状细胞癌(HNSCC)患者发生第二原发性恶性肿瘤(SPM)后的生存率。

方法

使用监测、流行病学和最终结果(SEER)数据库(1973 - 2011年)。采用带有对数秩检验的Kaplan - Meier方法,从SPM诊断时间起比较各治疗方法之间的总生存期(OS)和病因特异性生存期(CSS)。使用Cox比例回归模型调整危险因素对CSS的影响。

结果

共纳入3038例患者(5年OS为22.6%(21.0 - 24.3%))。对于头颈部(HN)SPM,接受“保守手术加放疗”的患者5年OS最佳(65.2%(48.9 - 86.9%));“保守手术”组5年CSS最佳(89.9%(85.6 - 94.5%))。对于肺部SPM,“根治性手术”组生存率最佳(2年OS分别为60.8%(56.0 - 66.1%),2年CSS为70.6%(65.8 - 75.8%))。食管SPM预后较差,各治疗组之间无差异。在肺部SPM中,年龄较小(p<0.001)和黑人种族(p<0.05)是最有利的CSS预测因素。

结论

与相应的原发性肿瘤相比,HNSCC后SPM的预后更差。在HN SPM中,保守手术加或不加放疗显示出最有利的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c6/5491341/fe3a189b576a/cureus-0009-00000001284-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c6/5491341/fe3a189b576a/cureus-0009-00000001284-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c6/5491341/fe3a189b576a/cureus-0009-00000001284-i01.jpg

相似文献

1
First Clinical Report on Comparative Treatment and Survival Outcomes in Second Cancers after Primary Head and Neck Cancer: A Population-Based Study.原发性头颈癌继发第二癌症的比较治疗与生存结果的首份临床报告:一项基于人群的研究
Cureus. 2017 May 29;9(5):e1284. doi: 10.7759/cureus.1284.
2
Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.头颈部鳞状细胞癌中头颈部与非头颈部第二原发性恶性肿瘤的患病率及转归:监测、流行病学和最终结果数据库分析
ORL J Otorhinolaryngol Relat Spec. 2016;78(2):61-9. doi: 10.1159/000443768. Epub 2016 Feb 25.
3
The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.局限性前列腺癌放疗时的年龄对第二原发性恶性肿瘤发生的影响。
Urol Oncol. 2018 Nov;36(11):500.e11-500.e19. doi: 10.1016/j.urolonc.2018.06.007. Epub 2018 Sep 21.
4
Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.第二原发性人乳头瘤病毒相关和非相关头颈部恶性肿瘤的风险与转归
Laryngoscope. 2019 Aug;129(8):1828-1835. doi: 10.1002/lary.27634. Epub 2018 Dec 24.
5
Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).韩国队列(1993 - 2010年)中头颈部癌后异时性第二原发性恶性肿瘤
PLoS One. 2015 Jul 28;10(7):e0134160. doi: 10.1371/journal.pone.0134160. eCollection 2015.
6
Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.头颈部鳞状细胞癌的二次癌症发生率、风险因素和特定死亡率。
Otolaryngol Head Neck Surg. 2013 Oct;149(4):579-86. doi: 10.1177/0194599813496373. Epub 2013 Jul 2.
7
The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study.第二原发恶性肿瘤对头颈部癌症幸存者的影响:一项全国性队列研究。
PLoS One. 2013 Apr 16;8(4):e62116. doi: 10.1371/journal.pone.0062116. Print 2013.
8
Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.头颈部癌症患者的同步癌:人乳头瘤病毒相关性口咽癌时代的风险。
Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988. Epub 2013 Feb 19.
9
Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.放射治疗与男性乳腺癌:一项基于人群的登记分析。
Am J Clin Oncol. 2016 Oct;39(5):458-62. doi: 10.1097/COC.0000000000000078.
10
Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.原发性头颈部血管肉瘤的特征与预后:一项基于监测、流行病学和最终结果计划(SEER)的1250例病例分析
Head Neck Pathol. 2019 Sep;13(3):378-385. doi: 10.1007/s12105-018-0978-3. Epub 2018 Oct 24.

引用本文的文献

1
Endoscopic Screening for Second Primary Tumors of the Esophagus Among Head and Neck Cancer Patients.对头颈部癌症患者进行内镜检查以筛查食管第二原发性肿瘤。
Front Oncol. 2022 Jun 7;12:906125. doi: 10.3389/fonc.2022.906125. eCollection 2022.
2
Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.头颈部鳞状细胞癌患者是否有可能从术后放疗的减量化中获益?:对接受标准治疗放疗的既往定义的低危患者人群进行的单中心回顾性分析。
Strahlenther Onkol. 2019 Jun;195(6):482-495. doi: 10.1007/s00066-018-1415-y. Epub 2019 Jan 4.

本文引用的文献

1
Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer.宫颈癌诊治后的第二原发癌。
Cancer Res Treat. 2016 Apr;48(2):641-9. doi: 10.4143/crt.2014.326. Epub 2015 Jul 17.
2
Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer.立体定向放射治疗与楔形切除术及楔形切除术联合铯-131近距离放射治疗在早期肺癌中的分析。
Brachytherapy. 2015 Sep-Oct;14(5):648-54. doi: 10.1016/j.brachy.2015.04.001. Epub 2015 May 19.
3
Causes of death in long-term survivors of head and neck cancer.
头颈部癌症长期幸存者的死因。
Cancer. 2014 May 15;120(10):1507-13. doi: 10.1002/cncr.28588. Epub 2014 Feb 22.
4
Treatment and survival in 10,429 patients with localized laryngeal cancer: a population-based analysis.10429 例局限性喉癌患者的治疗和生存情况:基于人群的分析。
Cancer. 2014 Jun 15;120(12):1810-7. doi: 10.1002/cncr.28608. Epub 2014 Mar 17.
5
Marital status and survival in patients with cancer.婚姻状况与癌症患者的生存。
J Clin Oncol. 2013 Nov 1;31(31):3869-76. doi: 10.1200/JCO.2013.49.6489. Epub 2013 Sep 23.
6
Decision making in the management of recurrent head and neck cancer.复发性头颈部癌的治疗决策。
Head Neck. 2014 Jan;36(1):144-51. doi: 10.1002/hed.23227. Epub 2013 Mar 8.
7
Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.头颈部癌症患者的同步癌:人乳头瘤病毒相关性口咽癌时代的风险。
Cancer. 2013 May 15;119(10):1832-7. doi: 10.1002/cncr.27988. Epub 2013 Feb 19.
8
Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.从不吸烟者中 HPV 相关口咽癌的第二原发恶性肿瘤风险较低。
Head Neck. 2013 Jun;35(6):794-9. doi: 10.1002/hed.23033. Epub 2012 Jun 19.
9
Preoperative chemoradiotherapy for esophageal or junctional cancer.术前放化疗治疗食管或食管胃交界癌。
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
10
Esophageal and esophagogastric junction cancers.食管癌和食管胃交界癌。
J Natl Compr Canc Netw. 2011 Aug 1;9(8):830-87. doi: 10.6004/jnccn.2011.0072.